Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-01

Clinical Trial Update: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term [NA]

View source ↗

Summary

A completed clinical trial evaluating aspirin dosing for patients with atherosclerotic cardiovascular disease; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Duke University | Conditions: Atherosclerotic Cardiovascular Disease | NA | Status: COMPLETED | Results posted: 2021-07-01